Audio Recording of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2026

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.1%1-day move

₹4497.00

prior close

₹4525.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.6+2.2+2.7+3.2-1.1+0.7-1.8-3.3-4.8-3.7-0.6+0.5+11.4—

Up moveDown movePending

AI summary

Torrent Pharmaceuticals has notified regulators and investors that the audio recording of their conference call discussing the audited financial results for Q4 and full year ended 31st March 2026 is now available on the company's website. This is a regulatory disclosure under SEBI LODR regulations. The actual recording contains the management commentary and Q&A session but the specific content is not included in this filing notice. The company had previously informed about these results on 12-May-26 and 16-May-26.

Likely market impact

This filing is administrative in nature, notifying investors where to access the audio discussion. The actual financial details, management guidance, and any signals for investors would be contained in the audio recording itself, not in this disclosure notice.